University of Sydney (USYD)

University / College


Location: Sydney, Australia (AU) AU

ISNI: 000000041936834X

ROR: https://ror.org/0384j8v12

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients (2021) Fuchs TL, Maclean F, Turchini J, Vargas AC, Bhattarai S, Agaimy A, Hartmann A, et al. Journal article Love, hate and tragedy: A three-part history of Bhutan-Cooch relations (2021) Chophel D, Booth J Other publication type Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis (2021) Zaremba A, Kramer R, De Temple V, Bertram S, Salzmann M, Gesierich A, Reinhardt L, et al. Journal article Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA) (2021) Sardanelli F, Trimboli RM, Houssami N, Gilbert FJ, Helbich TH, Alvarez Benito M, Balleyguier C, et al. Journal article A field guide to cultivating computational biology (2021) Way GP, Greene CS, Carninci P, Carvalho BS, De Hoon M, Finley S, Gosline SJC, et al. Journal article, Review article Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline (2021) Tomson CR, Cheung AK, Mann JF, Chang TI, Cushman WC, Furth SL, Hou FF, et al. Journal article Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis (2021) Meagher N, Koebel M, Anderson L, Tan A, Bolithon A, Anglesio M, Cohen P, et al. Conference contribution KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab D chemotherapy vs. placebo D chemotherapy, followed by adjuvant pembrolizumab vs. placebo for earlystage TNBC (2021) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kummel S, Bergh J, et al. Conference contribution Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, et al. Journal article Hemoglobin A1c patterns of youth with type 1 diabetes 10 years post diagnosis from 3 continents (2021) Sherr JL, Schwandt A, Phelan H, Clements MA, Holl RW, Benitez-Aguirre PZ, Miller KM, et al. Journal article